Operating Expenses Summary of Telescope Innovations Corp.

Telescope Innovations Corp.'s latest annual operating expenses in 2022 was 6.35 Million CAD , up 57.88% from previous year.
Telescope Innovations Corp.'s latest quarterly operating expenses in 2023 Q3 was 937.8 Thousand CAD , up 15.96% from previous quarter.
Telescope Innovations Corp. reported a annual operating expenses of 4.02 Million CAD in annual operating expenses 2021, up 2772.84% from previous year.
Telescope Innovations Corp. reported a annual operating expenses of 140.05 Thousand CAD in annual operating expenses 2020, down 0.0% from previous year.
Telescope Innovations Corp. reported a quarterly operating expenses of 808.71 Thousand CAD for 2023 Q2, up 1.86% from previous quarter.
Telescope Innovations Corp. reported a quarterly operating expenses of 793.98 Thousand CAD for 2023 Q1, down -41.33% from previous quarter.

Annual Operating Expenses Chart of Telescope Innovations Corp. (2022 - 2020)

Name	Operating Expenses	Operating Expenses Difference
Algernon Pharmaceuticals Inc.	5.19 Million CAD	-22.357%
Asep Medical Holdings Inc	7.74 Million CAD	17.954%
BetterLife Pharma Inc.	3.24 Million CAD	-96.044%
BioVaxys Technology Corp.	2.4 Million CAD	-164.392%
ChitogenX Inc.	2.83 Million CAD	-124.463%
Rapid Dose Therapeutics Corp.	4.2 Million CAD	-50.941%
Defence Therapeutics Inc.	12.65 Million CAD	49.807%
Entheon Biomedical Corp.	564.31 Thousand CAD	-1025.665%
Gemina Laboratories Ltd.	5.08 Million CAD	-24.901%
Glow Lifetech Corp.	25.71 Thousand CAD	-24602.695%
Lexston Life Sciences Corp.	674.71 Thousand CAD	-841.475%
Pharmala Biotech Holdings Inc.	1.21 Million CAD	-421.943%
Doseology Sciences Inc.	72.08 Thousand CAD	-8711.988%
MYND Life Sciences Inc.	1.47 Million CAD	-330.726%
Nova Mentis Life Science Corp.	1.2 Million CAD	-428.346%
PharmaTher Holdings Ltd.	3.04 Million CAD	-108.677%
PreveCeutical Medical Inc.	963.12 Thousand CAD	-559.551%